| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |